HealthEquity CFO granted 27,283 shares

HEALTHEQUITY, INC. reported that EVP & CFO James M. Lucania acquired 27,283 shares of common stock through a grant/award at no purchase price.

Accepted by SEC EDGAR 03/27/2026 - 05:14 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

HEALTHEQUITY, INC. reported that EVP & CFO James M. Lucania acquired 27,283 shares of common stock through a grant/award at no purchase price. These are restricted stock units, each representing one share. The award vests 25% on April 1, 2027, then 6.25% quarterly over the following twelve quarters. After this compensation grant, he directly holds 111,849 shares.

Insider Trade Summary

Grant/Award: 27,283 shares

Grant/Award 1 txn

Insider Lucania James M

Role EVP & CFO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	27,283	$0.00	$0.00

Holdings After Transaction: Common Stock — 111,849 shares (Direct)

Holdings Before and After: Common Stock, 84,566 to 111,849 shares (Direct)

Footnotes (1)

1. F1. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Shares vest as to 25% of the initial award on April 1, 2027. Shares shall vest as to 6.25% thereafter on the first day of each calendar quarter for the twelve calendar quarters following April 1, 2027.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did HealthEquity (HQY) report for its CFO?

HealthEquity reported that EVP & CFO James M. Lucania received a grant of 27,283 restricted stock units, each representing one share of common stock, as compensation. The award was recorded at a price of $0.00 per share and increased his direct holdings to 111,849 shares.

How many shares did the HealthEquity (HQY) CFO acquire in this Form 4?

The CFO acquired 27,283 shares of HealthEquity common stock through a restricted stock unit award. This grant was recorded at no purchase price and is part of his equity compensation. Following the grant, his directly owned position totals 111,849 shares of common stock.

What is the vesting schedule for the HealthEquity (HQY) CFO’s new stock units?

The restricted stock units vest 25% of the initial award on April 1, 2027. The remaining shares then vest in 6.25% installments on the first day of each calendar quarter for twelve quarters after April 1, 2027, creating a multi‑year, time-based vesting structure.

Are the CFO’s new HealthEquity (HQY) shares an open-market purchase?

No. The 27,283 shares reflect a grant or award, not an open-market purchase. The Form 4 identifies the transaction code as “A,” meaning a grant, award, or other acquisition, and the price per share is listed as $0.00, indicating compensation rather than a cash transaction.

How many HealthEquity (HQY) shares does the CFO own after this Form 4?

After the reported transaction, EVP & CFO James M. Lucania directly owns 111,849 shares of HealthEquity common stock. This total includes the 27,283 restricted stock units granted in the filing, which are scheduled to vest over several years under the disclosed vesting schedule.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lucania James M

(Last) (First) (Middle)

C/O HEALTHEQUITY, INC.

15 W. SCENIC POINTE DR., STE. 100

(Street)

DRAPER UTAH 84020

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HEALTHEQUITY, INC. [ HQY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/25/2026		A		27,283(1)	A	$0	111,849	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Shares vest as to 25% of the initial award on April 1, 2027. Shares shall vest as to 6.25% thereafter on the first day of each calendar quarter for the twelve calendar quarters following April 1, 2027.

Remarks:

The Power of Attorney given by Mr. Lucania was previously filed with the U.S. Securities and Exchange Commission on March 29, 2024 as an exhibit to a statement on Form 4 filed by Mr. Lucania with respect to HealthEquity, Inc. and is hereby incorporated by reference.

	/s/ Michael Newton, Attorney-in-Fact	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)